First-in-Class Mitogen-Activated Protein Kinase p38α: MAPK-Activated Protein Kinase-2 (MK2) Dual Signal Modulator...

Area of Science:

• Molecular Biology
• Pharmacology
• Immunology

Background:

• p38a Mitogen-activated Protein Kinase (MAPK) and its substrate MAPK-activated protein kinase (MK2) are key regulators of inflammatory responses.
• The small molecule UM101 demonstrated anti-inflammatory and lung-protective effects by targeting the p38a MAPK pathway.
• UM101's therapeutic utility was limited by poor aqueous solubility and suboptimal p38a binding affinity.

Purpose of the Study:

• To design and characterize GEn-1124, an analog of UM101 with improved physicochemical properties and enhanced p38a binding.
• To evaluate the efficacy of GEn-1124 in preclinical models of acute lung injury (ALI) and influenza pneumonia.
• To elucidate the novel mechanism of action of GEn-1124 in modulating p38a/MK2 signaling.

Main Methods:

• Surface Plasmon Resonance (SPR) was used to measure p38a binding affinity.
• In vitro assays assessed endothelial barrier stabilization in human pulmonary artery endothelial cells (hPAEC).
• In vivo studies evaluated survival rates in murine models of ALI and influenza pneumonia.
• RNASeq analysis was performed on TNFa-treated hPAEC to assess gene expression changes.
• Confocal immunofluorescence microscopy and SPR were used to analyze protein trafficking and binding interactions.

Main Results:

• GEn-1124 exhibited 18-fold greater p38a binding affinity and 11-fold improved aqueous solubility compared to UM101.
• GEn-1124 significantly enhanced lung protection and survival in murine ALI and influenza pneumonia models.
• GEn-1124 demonstrated a more restricted gene-modifying effect compared to the catalytic inhibitor SB203580.
• GEn-1124 was found to destabilize the activated p38a:MK2 complex, promoting intranuclear retention and signaling.

Conclusions:

• GEn-1124 is a potent analog of UM101 with superior properties for modulating p38a/MK2 signaling.
• GEn-1124's novel mechanism involves destabilizing the p38a:MK2 complex, leading to rebalanced pro- and anti-inflammatory signaling.
• GEn-1124 demonstrates significant therapeutic potential for treating inflammatory lung diseases such as ARDS.